Kotake Shigeru, Yago Toru, Kawamoto Manabu, Nanke Yuki
Institute of Rheumatology, Tokyo Women's Medical University.
Nihon Rinsho Meneki Gakkai Kaishi. 2009 Dec;32(6):466-71. doi: 10.2177/jsci.32.466.
Synovial tissues of patients with rheumatoid arthritis (RA) include factors regulating bone resorption, such as receptor activator NF-kappaB ligand (RANKL), TNF-alpha, IL-6, IL-17, and IFN-gamma. However, in addition to these cytokines, other factors expressed in synovial tissues may play a role in regulating bone resorption. In 2009, we demonstrated that novel peptides from T-cell leukemia translocation-associated gene (TCTA) protein expressed in synovial tissues from patients with RA inhibit human osteoclastogenesis, preventing cellular fusion via the interaction between TCTA protein and a putative counterpart molecule. Only a few studies on the role of TCTA protein have been reported, including our report published in 2009. In the current review paper, we summarized papers on TCTA protein before 2009 and our recent findings.
类风湿性关节炎(RA)患者的滑膜组织包含调节骨吸收的因子,如核因子κB受体活化因子配体(RANKL)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-17(IL-17)和干扰素-γ(IFN-γ)。然而,除了这些细胞因子外,滑膜组织中表达的其他因子可能在调节骨吸收中发挥作用。2009年,我们证明,类风湿性关节炎患者滑膜组织中表达的T细胞白血病易位相关基因(TCTA)蛋白产生的新型肽可抑制人破骨细胞生成,通过TCTA蛋白与假定的对应分子之间的相互作用阻止细胞融合。关于TCTA蛋白作用的研究报告较少,包括我们2009年发表的报告。在本综述论文中,我们总结了2009年之前关于TCTA蛋白的论文以及我们最近的研究发现。